Table 5 Coverage achieved for hospital-acquired bloodstream infections with empiric antimicrobial regimens (2012–2013)*
From: Trends in paediatric bloodstream infections at a South African referral hospital
Antibiotic susceptibility | OVERALL n = 159 | WARD n = 92 | PICU n = 67 | Ward vs PICU | |||
|---|---|---|---|---|---|---|---|
SUSCEPTIBLE | |||||||
Number (n) | Percentage (%) | Number (n) | Percentage (%) | Number (n) | Percentage (%) | p-value | |
piperacillin tazobactam + amikacin | 122 | 76.7 | 71 | 77.2 | 50 | 74.6 | 0.7 |
ertapenem | 110 | 69.1 | 71 | 77.2 | 40 | 59.7 | 0.02 |
meropenem | 112 | 70.4 | 70 | 76 | 42 | 62.7 | 0.08 |
meropenem + amikacin | 133 | 83.6 | 82 | 89.1 | 51 | 76 | 0.03 |
meropenem + vancomycin | 119 | 74.8 | 73 | 79.3 | 46 | 68.7 | 0.14 |